The role of the blood–brain barrier in the development and treatment of migraine and other pain disorders

Frontiers in Cellular Neuroscience

Volumn 8, Issue OCT, 2014, Pages

  DosSantos, Marcos F ^a,b   Holanda Afonso, Rosenilde C ^a   Lima, Rodrigo L ^a   DaSilva, Alexandre F ^b   Moura Neto, Vivaldo ^a,c  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Neuroendocrine Section   (Brazil)

Author keywords

Blood brain barrier; Blood nerve barrier; Blood spinal cord barrier; Inflammatory pain and opioids; Migraine; Neuropathic pain; Pain

Indexed keywords

BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; CENTRAL NERVOUS SYSTEM; HUMAN; INFLAMMATORY PAIN; MIGRAINE; NEUROPATHIC PAIN; NONHUMAN; PSYCHOGENIC PAIN; REVIEW; SIGNAL TRANSDUCTION;

EID: 84907755324     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00302     Document Type: Review

References (151)

1. Abbott, N. J., Rönnbäck, L., and Hansson, E. (2006). Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7, 41-53. doi: 10.1038/nrn1824
2. Alloui, A., Zimmermann, K., Mamet, J., Duprat, F., Noël, J., Chemin, J.,et al. (2006). TREK-1, a K+ channel involved in polymodal pain perception. EMBO J. 25, 2368-2376. doi: 10.1038/sj.emboj.7601116
3. Ambrosetto, P., Nicolini, F., Zoli, M., Cirillo, L., Feraco, P., and Bacci, A. (2014). Ophthalmoplegic migraine: from questions to answers. Cephalalgia doi: 10.1177/0333102414523843 [Epub ahead of print].
4. Antal, A., and Paulus, W. (2011). A case of refractory orofacial pain treated by transcranial direct current stimulation applied over hand motor area in combination with NMDA agonist drug intake. Brain Stimul. 4, 117-121. doi: 10.1016/j.brs.2010.09.003
5. Apkarian, A. V., Sosa, Y., Sonty, S., Levy, R. M., Harden, R. N., Parrish, T. B.,et al. (2004). Chronic back pain is associated with decreased prefrontal and thalamic gray matter density. J. Neurosci. 24, 10410-10415. doi: 10.1523/JNEUROSCI.2541-04.2004
6. Asghar, M. S., Hansen, A. E., Amin, F. M., Van Der Geest, R. J., Koning, P., Larsson, H. B.,et al. (2011). Evidence for a vascular factor in migraine. Ann. Neurol. 69, 635-645. doi: 10.1002/ana.22292
7. Ashina, M., Tvedskov, J. F., Lipka, K., Bilello, J., Penkowa, M., and Olesen, J. (2010). Matrix metalloproteinases during and outside of migraine attacks without aura. Cephalalgia 30, 303-310. doi: 10.1111/j.1468-2982.2009.01954.x
8. Basbaum, A. I., Bautista, D. M., Scherrer, G., and Julius, D. (2009). Cellular and molecular mechanisms of pain. Cell139, 267-284. doi: 10.1016/j.cell.2009.09.028
9. Beggs, S., Liu, X. J., Kwan, C., and Salter, M. W. (2010). Peripheral nerve injury and TRPV1-expressing primary afferent C-fibers cause opening of the blood-brain barrier. Mol. Pain 6:74. doi: 10.1186/1744-8069-6-74
10. Bell, I. M. (2014). Calcitonin gene-related peptide receptor antagonists: new therapeutic agents for migraine. J. Med. Chem. doi: 10.1021/jm500364u [Epub ahead of print].
11. Bernecker, C., Pailer, S., Kieslinger, P., Horejsi, R., Möller, R., Lechner, A.,et al. (2011). Increased matrix metalloproteinase activity is associated with migraine and migraine-related metabolic dysfunctions. Eur. J. Neurol.18, 571-576. doi: 10.1111/j.1468-1331.2010.03205.x
12. Bhaskar, S., Saeidi, K., Borhani, P., and Amiri, H. (2013). Recent progress in migraine pathophysiology: role of cortical spreading depression and magnetic resonance imaging. Eur. J. Neurosci. 38, 3540-3551. doi: 10.1111/ejn.12368
13. Bittner, S., Ruck, T., Fernández-Orth, J., and Meuth, S. G. (2014). TREK-king the blood-brain barrier. J. Neuroimmune Pharmacol. 9, 293-301. doi: 10.1007/s11481-014-9530-8
14. Bittner, S., Ruck, T., Schuhmann, M. K., Herrmann, A. M., Moha Ou Maati, H., Bobak, N.,et al. (2013). Endothelial TWIK-related potassium channel-1 (TREK1) regulates immune-cell trafficking into the CNS. Nat. Med. 19, 1161-1165. doi: 10.1038/nm.3303
15. Bouhassira, D., Lantéri-Minet, M., Attal, N., Laurent, B., and Touboul, C. (2008). Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 136, 380-387. doi: 10.1016/j.pain.2007.08.013
16. Brooks, T. A., Hawkins, B. T., Huber, J. D., Egleton, R. D., and Davis, T. P. (2005). Chronic inflammatory pain leads to increased blood-brain barrier permeability and tight junction protein alterations. Am. J. Physiol. Heart Circ. Physiol. 289, H738-H743. doi: 10.1152/ajpheart.01288.2004
17. Campos, C. R., Ocheltree, S. M., Hom, S., Egleton, R. D., and Davis, T. P. (2008). Nociceptive inhibition prevents inflammatory pain induced changes in the blood-brain barrier. Brain Res. 1221, 6-13. doi: 10.1016/j.brainres.2008.05.013
18. Casey, K. L., and Bushnell, M. C. (2000). Pain Imaging. Seattle: IASP Press.
19. Chen, M. J., Kress, B., Han, X., Moll, K., Peng, W., Ji, R. R.,et al. (2012). Astrocytic CX43 hemichannels and gap junctions play a crucial role in development of chronic neuropathic pain following spinal cord injury. Glia 60, 1660-1670. doi: 10.1002/glia.22384
20. Clark, A. K., and Malcangio, M. (2014). Fractalkine/CX3CR1 signaling during neuropathic pain. Front. Cell. Neurosci. 8:121. doi: 10.3389/fncel.2014.00121
21. Coull, J. A., Beggs, S., Boudreau, D., Boivin, D., Tsuda, M., Inoue, K.,et al. (2005). BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 438, 1017-1021. doi: 10.1038/nature04223
22. Cramer, S. P., Simonsen, H., Frederiksen, J. L., Rostrup, E., and Larsson, H. B. (2014). Abnormal blood-brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI. Neuroimage Clin.4, 182-189. doi: 10.1016/j.nicl.2013.12.001
23. Daniel, P. M., Lam, D. K., and Pratt, O. E. (1981). Changes in the effectiveness of the blood-brain and blood-spinal cord barriers in experimental allergic encephalomyelitis. J. Neurol. Sci. 52, 211-219. doi: 10.1016/0022-510X(81)90006-X
24. DaSilva, A. F., Becerra, L., Pendse, G., Chizh, B., Tully, S., and Borsook, D. (2008). Colocalized structural and functional changes in the cortex of patients with trigeminal neuropathic pain. PLoS ONE 3:e3396. doi: 10.1371/journal.pone.0003396
25. DaSilva, A. F., and DosSantos, M. F. (2012). The role of sensory fiber demography in trigeminal and postherpetic neuralgias. J. Dent. Res. 91, 17-24. doi: 10.1177/0022034511411300
26. DaSilva, A. F., Granziera, C., Tuch, D., Snyder, J., Vincent, M., and Hadjikhani, N. (2007a). Interictal alterations of the trigeminal somatosensory pathway and periaqueductal gray matter in migraine. Neuroreport 18, 301-305. doi: 10.1097/WNR.0b013e32801776bb
27. DaSilva, A. F., Granziera, C., Snyder, J., and Hadjikhani, N. (2007b). Thickening in the somatosensory cortex of patients with migraine. Neurology 69, 1990-1995. doi: 10.1212/01.wnl.0000291618.32247.2d
28. DaSilva, A. F., Mendonca, M. E., Zaghi, S., Lopes, M., DosSantos, M. F., Spierings, E. L.,et al. (2012). tDCS-induced analgesia and electrical fields in pain-related neural networks in chronic migraine. Headache 52, 1283-1295. doi: 10.1111/j.1526-4610.2012.02141.x
29. DaSilva, A. F., Tuch, D., Wiegell, M., and Hadjikhani, N. (2003). A primer on diffusion tensor imaging of anatomical substructures. Neurosurg. Focus 15:E4. doi: 10.3171/foc.2003.15.1.4
30. de Andrade, D. C., Mhalla, A., Adam, F., Texeira, M. J., and Bouhassira, D. (2011). Neuropharmacological basis of rTMS-induced analgesia: the role of endogenous opioids. Pain 152, 320-326. doi: 10.1016/j.pain.2010.10.032
31. de Groot, D. J., Van Der Deen, M., Le, T. K., Regeling, A., De Jong, S., and De Vries, E. G. (2007). Indomethacin induces apoptosis via a MRP1-dependent mechanism in doxorubicin-resistant small-cell lung cancer cells overexpressing MRP1. Br. J. Cancer 97, 1077-1083. doi: 10.1038/sj.bjc.6604010
32. Demeule, M., Beaudet, N., Régina, A., Besserer-Offroy,É., Murza, A., Tétreault, P.,et al. (2014). Conjugation of a brain-penetrant peptide with neurotensin provides antinociceptive properties. J. Clin. Invest. 124, 1199-1213. doi: 10.1172/JCI70647
33. Denekas, T., Tröltzsch, M., Vater, A., Klussmann, S., and Messlinger, K. (2006). Inhibition of stimulated meningeal blood flow by a calcitonin gene-related peptide binding mirror-image RNA oligonucleotide. Br. J. Pharmacol. 148, 536-543. doi: 10.1038/sj.bjp.0706742
34. DosSantos, M. F., Love, T. M., Martikainen, I. K., Nascimento, T. D., Fregni, F., Cummiford, C.,et al. (2012a). Immediate effects of tDCS on the μ-opioid system of a chronic pain patient. Front. Psychiatry 3:93. doi: 10.3389/fpsyt.2012.00093
35. DosSantos, M. F., Martikainen, I. K., Nascimento, T. D., Love, T. M., Deboer, M. D., Maslowski, E. C.,et al. (2012b). Reduced basal ganglia mu-opioid receptor availability in trigeminal neuropathic pain: a pilot study. Mol. Pain 8:74. doi: 10.1186/1744-8069-8-74
36. DosSantos, M. F., Martikainen, I. K., Nascimento, T. D., Love, T. M., Deboer, M. D., Schambra, H. M.,et al. (2014). Building up analgesia in humans via the endogenous μ-opioid system by combining placebo and active tDCS: a preliminary report. PLoS ONE 9:e102350. doi: 10.1371/journal.pone.0102350
37. DosSantos, M. F. H., and DaSilva, A. F. (2011). Functional and structural cortical neuroplasticity in trigeminal neuropathic pain. J. Pain Manage. 4:15.
38. Dreier, J. P., Jurkat-Rott, K., Petzold, G. C., Tomkins, O., Klingebiel, R., Kopp, U. A.,et al. (2005). Opening of the blood-brain barrier preceding cortical edema in a severe attack of FHM type II. Neurology 64, 2145-2147. doi: 10.1212/01.WNL.0000176298.63840.99
39. Echeverry, S., Shi, X. Q., Rivest, S., and Zhang, J. (2011). Peripheral nerve injury alters blood-spinal cord barrier functional and molecular integrity through a selective inflammatory pathway. J. Neurosci. 31, 10819-10828. doi: 10.1523/JNEUROSCI.1642-11.2011
40. Edvinsson, L. (2008). CGRP blockers in migraine therapy: where do they act? Br. J. Pharmacol. 155, 967-969. doi: 10.1038/bjp.2008.346
41. Edvinsson, L., and Tfelt-Hansen, P. (2008). The blood-brain barrier in migraine treatment. Cephalalgia 28, 1245-1258. doi: 10.1111/j.1468-2982.2008.01675.x
42. Eriksen, J. L., Sagi, S. A., Smith, T. E., Weggen, S., Das, P., Mclendon, D. C.,et al. (2003). NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo. J. Clin. Invest. 112, 440-449. doi: 10.1172/JCI18162
43. Fertleman, C. R., Baker, M. D., Parker, K. A., Moffatt, S., Elmslie, F. V., Abrahamsen, B.,et al. (2006). SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron 52, 767-774. doi: 10.1016/j.neuron.2006.10.006
44. Fregni, F., Gimenes, R., Valle, A. C., Ferreira, M. J., Rocha, R. R., Natalle, L.,et al. (2006). A randomized, sham-controlled, proof of principle study of transcranial direct current stimulation for the treatment of pain in fibromyalgia. Arthritis Rheum. 54, 3988-3998. doi: 10.1002/art.22195
45. Fricker, G., and Miller, D. S. (2004). Modulation of drug transporters at the blood-brain barrier. Pharmacology70, 169-176. doi: 10.1159/000075545
46. Ge, S., and Pachter, J. S. (2006). Isolation and culture of microvascular endothelial cells from murine spinal cord. J. Neuroimmunol. 177, 209-214. doi: 10.1016/j.jneuroim.2006.05.012
47. Gelfand, A. A., Gelfand, J. M., Prabakhar, P., and Goadsby, P. J. (2012). Ophthalmoplegic "migraine" or recurrent ophthalmoplegic cranial neuropathy: new cases and a systematic review. J. Child Neurol. 27, 759-766. doi: 10.1177/0883073811426502
48. Gillardon, F., Vogel, J., Hein, S., Zimmermann, M., and Uhlmann, E. (1997). Inhibition of carrageenan-induced spinal c-Fos activation by systemically administered c-fos antisense oligodeoxynucleotides may be facilitated by local opening of the blood-spinal cord barrier. J. Neurosci. Res. 47, 582-589. doi: 10.1002/(SICI)1097-4547(19970315)47:6<582::AID-JNR3>3.0.CO;2-9
49. Goadsby, P. J., Charbit, A. R., Andreou, A. P., Akerman, S., and Holland, P. R. (2009). Neurobiology of migraine. Neuroscience 161, 327-341. doi: 10.1016/j.neuroscience.2009.03.019
50. Gonçalves, F. M., Martins-Oliveira, A., Lacchini, R., Belo, V. A., Speciali, J. G., Dach, F.,et al. (2013). Matrix metalloproteinase (MMP)-2 gene polymorphisms affect circulating MMP-2 levels in patients with migraine with aura. Gene 512, 35-40. doi: 10.1016/j.gene.2012.09.109
51. Gordh, T., and Sharma, H. S. (2006). Chronic spinal nerve ligation induces microvascular permeability disturbances, astrocytic reaction, and structural changes in the rat spinal cord. Acta Neurochir. Suppl. 96, 335-340. doi: 10.1007/3-211-30714-1_70
52. Grände, G., Labruijere, S., Haanes, K. A., Maassenvandenbrink, A., and Edvinsson, L. (2014). Comparison of the vasodilator responses of isolated human and rat middle meningeal arteries to migraine related compounds. J. Headache Pain 15:22. doi: 10.1186/1129-2377-15-22
53. Gurney, K. J., Estrada, E. Y., and Rosenberg, G. A. (2006). Blood-brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation. Neurobiol. Dis. 23, 87-96. doi: 10.1016/j.nbd.2006.02.006
54. Gursoy-Ozdemir, Y., Qiu, J., Matsuoka, N., Bolay, H., Bermpohl, D., Jin, H.,et al. (2004). Cortical spreading depression activates and upregulates MMP-9. J. Clin. Invest. 113, 1447-1455. doi: 10.1172/JCI21227
55. Gustin, S. M., Peck, C. C., Wilcox, S. L., Nash, P. G., Murray, G. M., and Henderson, L. A. (2011). Different pain, different brain: thalamic anatomy in neuropathic and non-neuropathic chronic pain syndromes. J. Neurosci. 31, 5956-5964. doi: 10.1523/JNEUROSCI.5980-10.2011
56. Hackel, D., Krug, S. M., Sauer, R. S., Mousa, S. A., Böcker, A., Pflücke, D.,et al. (2012). Transient opening of the perineurial barrier for analgesic drug delivery. Proc. Natl. Acad. Sci. U.S.A. 109, E2018-E2027. doi: 10.1073/pnas.1120800109
57. Hall, G. C., Carroll, D., Parry, D., and Mcquay, H. J. (2006). Epidemiology and treatment of neuropathic pain: the UK primary care perspective. Pain 122, 156-162. doi: 10.1016/j.pain.2006.01.030
58. Han, C., Rush, A. M., Dib-Hajj, S. D., Li, S., Xu, Z., Wang, Y.,et al. (2006). Sporadic onset of erythermalgia: a gain-of-function mutation in Nav1.7. Ann. Neurol. 59, 553-558. doi: 10.1002/ana.20776
59. Hartz, A. M., Miller, D. S., and Bauer, B. (2010). Restoring blood-brain barrier P- glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease. Mol. Pharmacol. 77, 715-723. doi: 10.1124/mol.109.061754
60. Hawkins, B. T., and Davis, T. P. (2005). The blood-brain barrier/neurovascular unit in health and disease. Pharmacol. Rev. 57, 173-185. doi: 10.1124/pr.57.2.4
61. Huang, Y. N., Tsai, R. Y., Lin, S. L., Chien, C. C., Cherng, C. H., Wu, C. T.,et al. (2012). Amitriptyline attenuates astrocyte activation and morphine tolerance in rats: role of the PSD-95/NR1/nNOS/PKCγ signaling pathway. Behav. Brain Res. 229, 401-411. doi: 10.1016/j.bbr.2012.01.044
62. Huber, J. D., Campos, C. R., Mark, K. S., and Davis, T. P. (2006). Alterations in blood-brain barrier ICAM-1 expression and brain microglial activation after lambda-carrageenan-induced inflammatory pain. Am. J. Physiol. Heart Circ. Physiol. 290, H732-H740. doi: 10.1152/ajpheart.00747.2005
63. Huber, J. D., Hau, V. S., Borg, L., Campos, C. R., Egleton, R. D., and Davis, T. P. (2002). Blood-brain barrier tight junctions are altered during a 72-h exposure to lambda-carrageenan-induced inflammatory pain. Am. J. Physiol. Heart Circ. Physiol. 283, H1531-H1537. doi: 10.1152/ajpheart.00027.2002
64. Huber, J. D., Witt, K. A., Hom, S., Egleton, R. D., Mark, K. S., and Davis, T. P. (2001). Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression. Am. J. Physiol. Heart Circ. Physiol. 280, H1241-H1248.
65. Imamura, K., Takeshima, T., Fusayasu, E., and Nakashima, K. (2008). Increased plasma matrix metalloproteinase-9 levels in migraineurs. Headache 48, 135-139. doi: 10.1111/j.1526-4610.2007.00958.x
66. Ji, R. R., Berta, T., and Nedergaard, M. (2013). Glia and pain: is chronic pain a gliopathy? Pain 154(Suppl. 1), S10-S28. doi: 10.1016/j.pain.2013.06.022
67. Ji, R. R., and Suter, M. R. (2007). p38 MAPK, microglial signaling, and neuropathic pain. Mol. Pain 3:33. doi: 10.1186/1744-8069-3-33
68. Kalra, A., Urban, M. O., and Sluka, K. A. (2001). Blockade of opioid receptors in rostral ventral medulla prevents antihyperalgesia produced by transcutaneous electrical nerve stimulation (TENS). J. Pharmacol. Exp. Ther. 298, 257-263.
69. Kanda, T. (2013). Biology of the blood-nerve barrier and its alteration in immune mediated neuropathies. J. Neurol. Neurosurg. Psychiatry 84, 208-212. doi: 10.1136/jnnp-2012-302312
70. Kirk, J., Plumb, J., Mirakhur, M., and Mcquaid, S. (2003). Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination. J. Pathol. 201, 319-327. doi: 10.1002/path.1434
71. Klingelhöfer, J., Senolt, L., Baslund, B., Nielsen, G. H., Skibshøj, I., Pavelka, K.,et al. (2007). Up-regulation of metastasis-promoting S100A4 (Mts-1) in rheumatoid arthritis: putative involvement in the pathogenesis of rheumatoid arthritis. Arthritis Rheum. 56, 779-789. doi: 10.1002/art.22398
72. Kooij, G., Backer, R., Koning, J. J., Reijerkerk, A., Van Horssen, J., Van Der Pol, S. M.,et al. (2009). P-glycoprotein acts as an immunomodulator during neuroinflammation. PLoS ONE 4:e8212. doi: 10.1371/journal.pone.0008212
73. Kyrkanides, S., Moore, A. H., Olschowka, J. A., Daeschner, J. C., Williams, J. P., Hansen, J. T.,et al. (2002). Cyclooxygenase-2 modulates brain inflammation-related gene expression in central nervous system radiation injury. Brain Res. Mol. Brain Res. 104, 159-169. doi: 10.1016/S0169-328X(02)00353-4
74. La, J. H., and Gebhart, G. F. (2011). Colitis decreases mechanosensitive K2P channel expression and function in mouse colon sensory neurons. Am. J. Physiol. Gastrointest. Liver Physiol. 301, G165-G174. doi: 10.1152/ajpgi.00417.2010
75. Lal, V., Sahota, P., Singh, P., Gupta, A., and Prabhakar, S. (2009). Ophthalmoplegia with migraine in adults: is it ophthalmoplegic migraine? Headache 49, 838-850. doi: 10.1111/j.1526-4610.2009.01405.x
76. Leão, A. A. P. (1944). Spreading depression of activity in the cerebral cortex. J. Neurophysiol. 14, 359-390.
77. Leech, S., Kirk, J., Plumb, J., and Mcquaid, S. (2007). Persistent endothelial abnormalities and blood-brain barrier leak in primary and secondary progressive multiple sclerosis. Neuropathol. Appl. Neurobiol. 33, 86-98. doi: 10.1111/j.1365-2990.2006.00781.x
78. Leira, R., Sobrino, T., Rodríguez-Yáñnez, M., Blanco, M., Arias, S., and Castillo, J. (2007). Mmp-9 immunoreactivity in acute migraine. Headache 47, 698-702. doi: 10.1111/j.1526-4610.2006.00641.x
79. Leung, A., Fallah, A., and Shukla, S. (2014). Transcutaneous magnetic stimulation (tMS) in alleviating post-traumatic peripheral neuropathic pain states: a case series. Pain Med. 15, 1196-1199. doi: 10.1111/pme.12426
80. Lim, T. K., Shi, X. Q., Martin, H. C., Huang, H., Luheshi, G., Rivest, S.,et al. (2014). Blood-nerve barrier dysfunction contributes to the generation of neuropathic pain and allows targeting of injured nerves for pain relief. Pain 155, 954-967. doi: 10.1016/j.pain.2014.01.026
81. Lin, Z. P., Zhu, Y. L., Johnson, D. R., Rice, K. P., Nottoli, T., Hains, B. C.,et al. (2008). Disruption of cAMP and prostaglandin E2 transport by multidrug resistance protein 4 deficiency alters cAMP-mediated signaling and nociceptive response. Mol. Pharmacol. 73, 243-251. doi: 10.1124/mol.107.039594
82. Lipton, R. B., Bigal, M. E., Diamond, M., Freitag, F., Reed, M. L., Stewart, W. F.,et al. (2007). Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 68, 343-349. doi: 10.1212/01.wnl.0000252808.97649.21
83. Lu, P., Gonzales, C., Chen, Y., Adedoyin, A., Hummel, M., Kennedy, J. D.,et al. (2009). CNS penetration of small molecules following local inflammation, widespread systemic inflammation or direct injury to the nervous system. Life Sci. 85, 450-456. doi: 10.1016/j.lfs.2009.07.009
84. Luk, K., Boatman, S., Johnson, K. N., Dudek, O. A., Ristau, N., Vang, D.,et al. (2012). Influence of morphine on pericyte-endothelial interaction: implications for antiangiogenic therapy. J. Oncol. 2012:458385. doi: 10.1155/2012/458385
85. Marlow, N. M., Bonilha, H. S., and Short, E. B. (2013). Efficacy of transcranial direct current stimulation and repetitive transcranial magnetic stimulation for treating fibromyalgia syndrome: a systematic review. Pain Pract.13, 131-145. doi: 10.1111/j.1533-2500.2012.00562.x
86. Martins-Ferreira, H., Nedergaard, M., and Nicholson, C. (2000). Perspectives on spreading depression. Brain Res. Brain Res. Rev. 32, 215-234. doi: 10.1016/S0165-0173(99)00083-1
87. Martins-Oliveira, A., Gonçalves, F. M., Speciali, J. G., Fontana, V., Izidoro-Toledo, T. C., Belo, V. A.,et al. (2012). Specific matrix metalloproteinase 9 (MMP-9) haplotype affect the circulating MMP-9 levels in women with migraine. J. Neuroimmunol. 252, 89-94. doi: 10.1016/j.jneuroim.2012.07.016
88. McCaffrey, G., Staatz, W. D., Sanchez-Covarrubias, L., Finch, J. D., Demarco, K., Laracuente, M. L.,et al. (2012). P-glycoprotein trafficking at the blood-brain barrier altered by peripheral inflammatory hyperalgesia. J. Neurochem. 122, 962-975. doi: 10.1111/j.1471-4159.2012.07831.x
89. McMahon, S. B. (2013). Wall and Melzack's Textbook of Pain. Philadelphia: Elsevier/Saunders.
90. Merskey, H., Bogduk, N., and International Association for the Study Of Pain. (1994). Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms. Seattle: IASP Press.
91. Miglio, L., Feraco, P., Tani, G., and Ambrosetto, P. (2010). Computed tomography and magnetic resonance imaging findings in ophthalmoplegic migraine. Pediatr. Neurol. 42, 434-436. doi: 10.1016/j.pediatrneurol.2010.02.005
92. Miller, D. S. (2010). Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier. Trends Pharmacol. Sci. 31, 246-254. doi: 10.1016/j.tips.2010.03.003
93. Minagar, A., and Alexander, J. S. (2003). Blood-brain barrier disruption in multiple sclerosis. Mult. Scler. 9, 540-549. doi: 10.1191/1352458503ms965oa
94. Morgan, L., Shah, B., Rivers, L. E., Barden, L., Groom, A. J., Chung, R.,et al. (2007). Inflammation and dephosphorylation of the tight junction protein occludin in an experimental model of multiple sclerosis. Neuroscience 147, 664-673. doi: 10.1016/j.neuroscience.2007.04.051
95. Morrissey, S. P., Stodal, H., Zettl, U., Simonis, C., Jung, S., Kiefer, R.,et al. (1996). In vivo MRI and its histological correlates in acute adoptive transfer experimental allergic encephalomyelitis. Quantification of inflammation and oedema. Brain 119(Pt 1), 239-248. doi: 10.1093/brain/119.1.239
96. Myers, R. R., James, H. E., and Powell, H. C. (1985). Laser injury of peripheral nerve: a model for focal endoneurial damage. J. Neurol. Neurosurg. Psychiatry 48, 1265-1268. doi: 10.1136/jnnp.48.12.1265
97. Myers, R. R., Powell, H. C., Heckman, H. M., Costello, M. L., and Katz, J. (1981). Biophysical and pathological effects of cryogenic nerve lesion. Ann. Neurol. 10, 478-485. doi: 10.1002/ana.410100512
98. Nishioku, T., Furusho, K., Tomita, A., Ohishi, H., Dohgu, S., Shuto, H.,et al. (2011). Potential role for S100A4 in the disruption of the blood-brain barrier in collagen-induced arthritic mice, an animal model of rheumatoid arthritis. Neuroscience 189, 286-292. doi: 10.1016/j.neuroscience.2011.05.044
99. Nishioku, T., Yamauchi, A., Takata, F., Watanabe, T., Furusho, K., Shuto, H.,et al. (2010). Disruption of the blood-brain barrier in collagen-induced arthritic mice. Neurosci. Lett. 482, 208-211. doi: 10.1016/j.neulet.2010.07.035
100. Noseda, R., and Burstein, R. (2013). Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, CSD, sensitization and modulation of pain. Pain 154(Suppl. 1) S44-S53. doi: 10.1016/j.pain.2013.07.021
101. Oderda, G. (2012). Challenges in the management of acute postsurgical pain. Pharmacotherapy 32, 6S-11S. doi: 10.1002/j.1875-9114.2012.01177.x
102. Olesen, J., Burstein, R., Ashina, M., and Tfelt-Hansen, P. (2009). Origin of pain in migraine: evidence for peripheral sensitisation. Lancet Neurol. 8, 679-690. doi: 10.1016/S1474-4422(09)70090-0
103. Padden, M., Leech, S., Craig, B., Kirk, J., Brankin, B., and Mcquaid, S. (2007). Differences in expression of junctional adhesion molecule-A and beta-catenin in multiple sclerosis brain tissue: increasing evidence for the role of tight junction pathology. Acta Neuropathol. 113, 177-186. doi: 10.1007/s00401-006-0145-x
104. Pan, W., Banks, W. A., and Kastin, A. J. (1997). Permeability of the blood-brain and blood-spinal cord barriers to interferons. J. Neuroimmunol. 76, 105-111. doi: 10.1016/S0165-5728(97)00034-9
105. Parepally, J. M., Mandula, H., and Smith, Q. R. (2006). Brain uptake of nonsteroidal anti-inflammatory drugs: ibuprofen, flurbiprofen, and indomethacin. Pharm. Res. 23, 873-881. doi: 10.1007/s11095-006-9905-5
106. Plumb, J., Mcquaid, S., Mirakhur, M., and Kirk, J. (2002). Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis. Brain Pathol. 12, 154-169. doi: 10.1111/j.1750-3639.2002.tb00430.x
107. Potschka, H. (2012). Role of CNS efflux drug transporters in antiepileptic drug delivery: overcoming CNS efflux drug transport. Adv. Drug Deliv. Rev. 64, 943-952. doi: 10.1016/j.addr.2011.12.007
108. Powell, H. C., Myers, R. R., Mizisin, A. P., Olee, T., and Brostoff, S. W. (1991). Response of the axon and barrier endothelium to experimental allergic neuritis induced by autoreactive T cell lines. Acta Neuropathol. 82, 364-377. doi: 10.1007/BF00296547
109. Prockop, L. D., Naidu, K. A., Binard, J. E., and Ransohoff, J. (1995). Selective permeability of [3H]-D-mannitol and [14C]-carboxyl-inulin across the blood-brain barrier and blood-spinal cord barrier in the rabbit. J. Spinal Cord Med. 18, 221-226.
110. Radu, B. M., Bramanti, P., Osculati, F., Flonta, M. L., Radu, M., Bertini, G.,et al. (2013). Neurovascular unit in chronic pain. Mediators Inflamm. 2013:648268. doi: 10.1155/2013/648268
111. Raghavendra, V., Tanga, F., and Deleo, J. A. (2003). Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J. Pharmacol. Exp. Ther. 306, 624-630. doi: 10.1124/jpet.103.052407
112. Rasmussen, B. K. (1995). Epidemiology of migraine. Biomed. Pharmacother. 49, 452-455. doi: 10.1016/0753-3322(96)82689-8
113. Reid, G., Wielinga, P., Zelcer, N., Van Der Heijden, I., Kuil, A., De Haas, M.,et al. (2003). The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs. Proc. Natl. Acad. Sci. U.S.A. 100, 9244-9249. doi: 10.1073/pnas.1033060100
114. Reijerkerk, A., Lakeman, K. A., Drexhage, J. A., Van Het Hof, B., Van Wijck, Y., Van Der Pol, S. M.,et al. (2012). Brain endothelial barrier passage by monocytes is controlled by the endothelin system. J. Neurochem. 121, 730-737. doi: 10.1111/j.1471-4159.2011.07393.x
115. Ronaldson, P. T., and Davis, T. P. (2011). Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery. Ther. Deliv. 2, 1015-1041. doi: 10.4155/tde.11.67
116. Ronaldson, P. T., and Davis, T. P. (2013). Targeted drug delivery to treat pain and cerebral hypoxia. Pharmacol. Rev. 65, 291-314. doi: 10.1124/pr.112.005991
117. Ronaldson, P. T., Persidsky, Y., and Bendayan, R. (2008). Regulation of ABC membrane transporters in glial cells: relevance to the pharmacotherapy of brain HIV-1 infection. Glia 56, 1711-1735. doi: 10.1002/glia.20725
118. Rosenbaum, C., Röhrs, S., Müller, O., and Waldmann, H. (2005). Modulation of MRP-1-mediated multidrug resistance by indomethacin analogues. J. Med. Chem. 48, 1179-1187. doi: 10.1021/jm0499099
119. Rosenberg, G. A. (2012). Neurological diseases in relation to the blood-brain barrier. J. Cereb. Blood Flow Metab.32, 1139-1151. doi: 10.1038/jcbfm.2011.197
120. Rosenberg, G. A., Cunningham, L. A., Wallace, J., Alexander, S., Estrada, E. Y., Grossetete, M.,et al. (2001). Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res. 893, 104-112. doi: 10.1016/S0006-8993(00)03294-7
121. Rubin, L. L., and Staddon, J. M. (1999). The cell biology of the blood-brain barrier. Annu. Rev. Neurosci. 22, 11-28. doi: 10.1146/annurev.neuro.22.1.11
122. 2+ channel in non-excitable microglial cells in mice is involved in the pathophysiology of neuropathic pain. Biochem. Biophys. Res. Commun. 450, 142-147. doi: 10.1016/j.bbrc.2014.05.103
123. Sanchez-Covarrubias, L., Slosky, L. M., Thompson, B. J., Zhang, Y., Laracuente, M. L., Demarco, K. M.,et al. (2014). P-glycoprotein modulates morphine uptake into the CNS: a role for the non-steroidal anti-inflammatory drug diclofenac. PLoS ONE 9:e88516. doi: 10.1371/journal.pone.0088516
124. Sarrouilhe, D., Dejean, C., and Mesnil, M. (2014). Involvement of gap junction channels in the pathophysiology of migraine with aura. Front. Physiol. 5:78. doi: 10.3389/fphys.2014.00078
125. Seelbach, M. J., Brooks, T. A., Egleton, R. D., and Davis, T. P. (2007). Peripheral inflammatory hyperalgesia modulates morphine delivery to the brain: a role for P-glycoprotein. J. Neurochem. 102, 1677-1690. doi: 10.1111/j.1471-4159.2007.04644.x
126. Sharma, H. S. (2005). Pathophysiology of blood-spinal cord barrier in traumatic injury and repair. Curr. Pharm. Des. 11, 1353-1389. doi: 10.2174/1381612053507837
127. Sharma, H. S., and Winkler, T. (2002). Assessment of spinal cord pathology following trauma using early changes in the spinal cord evoked potentials: a pharmacological and morphological study in the rat. Muscle Nerve Suppl. 11, S83-S91. doi: 10.1002/mus.10152
128. Siegel, G. J. (1999). Basic Neurochemistry: Molecular, Cellular, and Medical Aspects. Philadelphia: Lippincott Williams & Wilkins.
129. Silberstein, S., Olesen, J., Bousser, M., Diener, H., Dodick, D., First, M.,et al. (2005). The International classification of headache disorders, 2nd edition (ICHD-II) - revision of criteria for 8.2 medication-overuse headache. Cephalalgia 25, 460-465. doi: 10.1111/j.1468-2982.2005.00878.x
130. Siqueira, S. R., Alves, B., Malpartida, H. M., Teixeira, M. J., and Siqueira, J. T. (2009). Abnormal expression of voltage-gated sodium channels Nav1.7, Nav1.3 and Nav1.8 in trigeminal neuralgia. Neuroscience 164, 573-577. doi: 10.1016/j.neuroscience.2009.08.037
131. Sluka, K. A., and Chandran, P. (2002). Enhanced reduction in hyperalgesia by combined administration of clonidine and TENS. Pain 100, 183-190. doi: 10.1016/S0304-3959(02)00294-4
132. Sluka, K. A., Deacon, M., Stibal, A., Strissel, S., and Terpstra, A. (1999). Spinal blockade of opioid receptors prevents the analgesia produced by TENS in arthritic rats. J. Pharmacol. Exp. Ther. 289, 840-846.
133. Stovner, L., Hagen, K., Jensen, R., Katsarava, Z., Lipton, R., Scher, A.,et al. (2007). The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 27, 193-210. doi: 10.1111/j.1468-2982.2007.01288.x
134. Summ, O., and Evers, S. (2013). Mechanism of action of indomethacin in indomethacin-responsive headaches. Curr. Pain Headache Rep. 17:327. doi: 10.1007/s11916-013-0327-x
135. Svensson, C. I., Marsala, M., Westerlund, A., Calcutt, N. A., Campana, W. M., Freshwater, J. D.,et al. (2003). Activation of p38 mitogen-activated protein kinase in spinal microglia is a critical link in inflammation-induced spinal pain processing. J. Neurochem. 86, 1534-1544. doi: 10.1046/j.1471-4159.2003.01969.x
136. Taylor, J. J., Borckardt, J. J., and George, M. S. (2012). Endogenous opioids mediate left dorsolateral prefrontal cortex rTMS-induced analgesia. Pain 153, 1219-1225. doi: 10.1016/j.pain.2012.02.030
137. Tenorio, G., Kulkarni, A., and Kerr, B. J. (2013). Resident glial cell activation in response to perispinal inflammation leads to acute changes in nociceptive sensitivity: implications for the generation of neuropathic pain. Pain 154, 71-81. doi: 10.1016/j.pain.2012.09.008
138. Tfelt-Hansen, P., and Olesen, J. (2011). Possible site of action of CGRP antagonists in migraine. Cephalalgia 31, 748-750. doi: 10.1177/0333102411398403
139. Thissen, S., Vos, I. G., Schreuder, T. H., Schreurs, W. M., Postma, L. A., and Koehler, P. (2014). Persistent migraine aura: new cases, a literature review, and ideas about pathophysiology. Headache 54, 1290-1309. doi: 10.1111/head.12392
140. Tsuda, M., Shigemoto-Mogami, Y., Koizumi, S., Mizokoshi, A., Kohsaka, S., Salter, M. W.,et al. (2003). P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424, 778-783. doi: 10.1038/nature01786
141. Tsukamoto, T., and Nigam, S. K. (1997). Tight junction proteins form large complexes and associate with the cytoskeleton in an ATP depletion model for reversible junction assembly. J. Biol. Chem. 272, 16133-16139. doi: 10.1074/jbc.272.26.16133
142. Turk, D. C. (2002). Clinical effectiveness and cost-effectiveness of treatments for patients with chronic pain. Clin. J. Pain 18, 355-365. doi: 10.1097/00002508-200211000-00003
143. van Hecke, O., Austin, S. K., Khan, R. A., Smith, B. H., and Torrance, N. (2014). Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain 155, 654-662. doi: 10.1016/j.pain.2013.11.013
144. Wager, T. D., Atlas, L. Y., Lindquist, M. A., Roy, M., Woo, C. W., and Kross, E. (2013). An fMRI-based neurologic signature of physical pain. N. Engl. J. Med. 368, 1388-1397. doi: 10.1056/NEJMoa1204471
145. Watson, D. J., Rhodes, T., and Guess, H. A. (2003). All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database. J. Rheumatol.30, 1196-1202.
146. Wilcox, S. L., Gustin, S. M., Eykman, E. N., Fowler, G., Peck, C. C., Murray, G. M.,et al. (2013). Trigeminal nerve anatomy in neuropathic and non-neuropathic orofacial pain patients. J. Pain 14, 865-872. doi: 10.1016/j.jpain.2013.02.014
147. Williams, J. T., Ingram, S. L., Henderson, G., Chavkin, C., Von Zastrow, M., Schulz, S.,et al. (2013). Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance. Pharmacol. Rev. 65, 223-254. doi: 10.1124/pr.112.005942
148. Xanthos, D. N., Püngel, I., Wunderbaldinger, G., and Sandkühler, J. (2012). Effects of peripheral inflammation on the blood-spinal cord barrier. Mol. Pain 8:44. doi: 10.1186/1744-8069-8-44
149. Yang, Y., Estrada, E. Y., Thompson, J. F., Liu, W., and Rosenberg, G. A. (2007). Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J. Cereb. Blood Flow Metab. 27, 697-709. doi: 10.1038/sj.jcbfm.9600375
150. Zeller, J., Poulsen, K. T., Sutton, J. E., Abdiche, Y. N., Collier, S., Chopra, R.,et al. (2008). CGRP function-blocking antibodies inhibit neurogenic vasodilatation without affecting heart rate or arterial blood pressure in the rat. Br. J. Pharmacol. 155, 1093-1103. doi: 10.1038/bjp.2008.334
151. Zlokovic, B. V. (2008). The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57, 178-201. doi: 10.1016/j.neuron.2008.01.003